LL-37

Description

LL-37 is an endogenous cathelicidin with a broad spectrum of antimicrobial activity. It improves skin barrier functions, accelerates wound healing, and has a moderate anti-inflammatory effect. It is used in the treatment of acne, skin infections, and post-procedure rehabilitation.

LL-37 is a highly concentrated form of cathelicidin designed for intensive immune and regenerative support. Its rapid bioavailability activates antimicrobial pathways, enhances barrier protection, and stabilizes inflammatory responses.
The peptide improves microcirculation, reduces bacterial and viral load, accelerates epithelial regeneration, and strengthens skin immune stability. LL-37 is especially effective in situations requiring strong and immediate support post-injury, during periods of reduced immune resilience, or after aesthetic and medical procedures.

LL-37 is suited for patients who need accelerated healing, reduced inflammation, or reinforcement of natural defense mechanisms. It is used in regenerative schemes, immune-support programs, post-procedure care, and comprehensive skin-healing and anti-inflammatory protocols.